Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy

被引：0
|
作者：
Fowler, D. W. [1 ]
Copier, J. [1 ]
Wilson, N. [1 ]
Dalgleish, A. G. [1 ]
Bodman-Smith, M. D. [1 ]
机构：
[1] St Georges Univ London, London, England
来源：
IMMUNOLOGY | 2011年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [1] Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
    Daniel W. Fowler
    John Copier
    Natalie Wilson
    Angus G. Dalgleish
    Mark D. Bodman-Smith
    Cancer Immunology, Immunotherapy, 2012, 61 : 535 - 547
  • [2] Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
    Fowler, Daniel W.
    Copier, John
    Wilson, Natalie
    Dalgleish, Angus G.
    Bodman-Smith, Mark D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (04) : 535 - 547
  • [3] Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity
    Ramsay, Alan G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (03) : 313 - 325
  • [4] A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia Expands Anti-Tumour T Cell Responses at Remission
    Hart, Derek N. J.
    Hsu, Jennifer L.
    Bryant, Christian E.
    Papadimitrious, Michael S.
    Kong, Benjamin
    Gasiorowski, Robin E.
    Orellana, Daniel W.
    McGuire, Helen
    de St Groth, Barbara Fazekas
    Joshua, Douglas E.
    Ho, Phoebe Joy
    Larsen, Stephen R.
    Iland, Harry J.
    Gibson, John
    Clark, Georgina J.
    Fromm, Phillip D.
    BLOOD, 2017, 130
  • [5] A Blood Dendritic Cell Vaccine for acute myeloid leukemia expands anti-tumour T Cell Responses at remission
    Fromm, P.
    Hsu, J.
    Bryant, C.
    Papadimitrious, M.
    Kong, B.
    Gasiorowski, R.
    Orellana, D.
    McGuire, H.
    de St Groth, B.
    Joshua, D.
    Ho, P. J.
    Larsen, S.
    Iland, H.
    Gibson, J.
    Clark, G.
    Hart, D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 74 - 75
  • [6] Assessing T-cell responses in anticancer immunotherapy Dendritic cells or myeloid-derived suppressor cells?
    Escors, David
    Liechtenstein, Therese
    Perez-Janices, Noemi
    Schwarze, Julia
    Dufait, Ines
    Goyvaerts, Cleo
    Lanna, Alessio
    Arce, Frederick
    Blanco-Luquin, Idoia
    Kochan, Grazyna
    Guerrero-Setas, David
    Breckpot, Karine
    ONCOIMMUNOLOGY, 2013, 2 (10):
  • [7] Idiotype- or MM cell lysate-pulsed autologous dendritic cells are poor ex vivo inducers of anti-tumour T-cell responses to myeloma
    Garderet, L
    Mazurier, C
    Pellat-Deceunynck, C
    Karim, A
    Baudin, B
    Funck-Brentano, C
    Bouchet, S
    Geffroy, A
    Bataille, R
    Gorin, N
    Lopez, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S249 - S249
  • [8] Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
    Yeku, Oladapo O.
    Brentjens, Renier J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 412 - 418
  • [9] Iron Boosts Antitumor Type 1 T-cell Responses and Anti-PD1 Immunotherapy
    Porte, Sarah
    Audemard-Verger, Alexandra
    Wu, Christian
    Durand, Aurelie
    Level, Theo
    Giraud, Lea
    Lombes, Amelie
    Germain, Mathieu
    Pierre, Remi
    Saintpierre, Benjamin
    Lambert, Mireille
    Auffray, Cedric
    Peyssonnaux, Carole
    Goldwasser, Francois
    Vaulont, Sophie
    Alves-Guerra, Marie-Clotilde
    Dentin, Renaud
    Lucas, Bruno
    Martin, Bruno
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (09) : 1252 - 1267
  • [10] Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway
    Pouniotis, DS
    Apostolopoulos, V
    Pietersz, GA
    IMMUNOLOGY, 2006, 117 (03) : 329 - 339
12345